Pricing Log in Create free account

Fortrea Holdings Inc. (FTRE) vs Sarepta Therapeutics, Inc. (SRPT)

Fortrea Holdings Inc. and Sarepta Therapeutics, Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Sarepta Therapeutics, Inc. are of similar size ($2.0B and $1.9B). Fortrea Holdings Inc. grew revenue faster over the last twelve months: −3.38% against −19.0%. Fortrea Holdings Inc. has the higher net margin (−2.58% vs −5.86%) and the higher return on invested capital (0.59% vs −2.03%). Across the 19 metrics below, Sarepta Therapeutics, Inc. leads on 10 and Fortrea Holdings Inc. on 9.

Valuation

Metric FTRE SRPT Biotechnology median
P/E n/m n/m 10.60
P/S 0.79 0.96 9.40
P/B 3.94 1.23 2.13
Price to free cash flow 12.27 11.07 25.18
EV/EBITDA 32.06 n/m 0.66
EV/Sales 1.10 0.95 9.02
Earnings yield (3.34%) (6.21%) (32.88%)
Free cash flow yield 8.15% 9.04% (23.13%)

Profitability

Metric FTRE SRPT Biotechnology median
Gross margin 20.00% 0.00% 68.51%
Operating margin 0.48% (2.50%) 0.00%
Net margin (2.58%) (5.86%) 0.00%
Free cash flow margin 6.41% 9.02% 0.00%
Return on equity (12.34%) (8.05%) (51.96%)
Return on assets (2.51%) (3.44%) (46.06%)
Return on invested capital 0.59% (2.03%) 0.00%

Growth

Metric FTRE SRPT Biotechnology median
Revenue growth (TTM) (3.38%) (18.95%) 6.76%
EPS growth (last fiscal year) (194.55%) (404.70%) 29.88%
Revenue growth, 5-year CAGR 1.09% 32.41% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTRE SRPT Biotechnology median
Debt to equity 1.98 0.56 0.00
Current ratio 0.97 3.46 4.97
Net debt to EBITDA 266.13 0.17 1.01

Dividend

Metric FTRE SRPT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FTRE SRPT Biotechnology median
Market cap 1.97b 1.86b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack